Adaptive Phage News Today

Phage Viruses That Target Bacteria Have Been Known for a Century but There Are Still No Clinical Trials – Though Compassionate Treatment of Patients With Pseudomonas Shows Huge Success

Lobbying revenues at K Street’s top firms began to rebound from a slower start to 2023, as lawmakers set to work on a slew of must-pass bills.

Infectious Disease News | Antibiotic-resistant infections, which have been on the rise for years, were the cause of more than 1.2 million deaths worldwide in 2019, according to estimates published this year in The Lancet.In the United States alone, the CDC reported that more than 2.8 million infections are caused by antibiotic-resistant pathogens annually, resulting in at least 35,000 deaths.

Former Alabama Rep. Bradley Byrne has registered to lobby for the first time since leaving office, according to quarterly disclosures filed this month.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

OYST earnings call for the period ending December 31, 2021.

View the winners of the 2021 BioBuzz Awards, a celebration of the exciting work being done by the BioHealth Capital Region community.

GAITHERSBURG, Md.--(BUSINESS WIRE)--Nov 2, 2021--

Published: Jul 02, 2021 By Alex Keown OcuTerra Therapeutics – David J. Tanzer was named Chief Medical Officer and Executive Vice President, Clinical and Medical Affairs for Boston-based OcuTerra. Prior to joining OcuTerra, Tanzer served as Global Executive Medical Director in the Novartis ophthalmology franchise. Before that, he served as the CMO at Abbott Medical Optics. He also led the Navy Refractive Surgery Program in San Diego, participating as principal or co-investigator in ove...